Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Jul 18;70(3):331-341.
doi: 10.1016/j.jacc.2017.05.030.

Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial

Joseph G Rogers  1 , Chetan B Patel  2 , Robert J Mentz  2 , Bradi B Granger  3 , Karen E Steinhauser  4 , Mona Fiuzat  5 , Patricia A Adams  5 , Adam Speck  5 , Kimberly S Johnson  2 , Arun Krishnamoorthy  6 , Hongqiu Yang  7 , Kevin J Anstrom  8 , Gwen C Dodson  5 , Donald H Taylor Jr  9 , Jerry L Kirchner  7 , Daniel B Mark  2 , Christopher M O'Connor  10 , James A Tulsky  11
Affiliations
Randomized Controlled Trial

Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial

Joseph G Rogers et al. J Am Coll Cardiol. .

Abstract

Background: Advanced heart failure (HF) is characterized by high morbidity and mortality. Conventional therapy may not sufficiently reduce patient suffering and maximize quality of life.

Objectives: The authors investigated whether an interdisciplinary palliative care intervention in addition to evidence-based HF care improves certain outcomes.

Methods: The authors randomized 150 patients with advanced HF between August 15, 2012, and June 25, 2015, to usual care (UC) (n = 75) or UC plus a palliative care intervention (UC + PAL) (n = 75) at a single center. Primary endpoints were 2 quality-of-life measurements, the Kansas City Cardiomyopathy Questionnaire (KCCQ) overall summary and the Functional Assessment of Chronic Illness Therapy-Palliative Care scale (FACIT-Pal), assessed at 6 months. Secondary endpoints included assessments of depression and anxiety (measured via the Hospital Anxiety and Depression Scale [HADS]), spiritual well-being (measured via the FACIT-Spiritual Well-Being scale [FACIT-Sp]), hospitalizations, and mortality.

Results: Patients randomized to UC + PAL versus UC alone had clinically significant incremental improvement in KCCQ and FACIT-Pal scores from randomization to 6 months (KCCQ difference = 9.49 points, 95% confidence interval [CI]: 0.94 to 18.05, p = 0.030; FACIT-Pal difference = 11.77 points, 95% CI: 0.84 to 22.71, p = 0.035). Depression improved in UC + PAL patients (HADS-depression difference = -1.94 points; p = 0.020) versus UC-alone patients, with similar findings for anxiety (HADS-anxiety difference = -1.83 points; p = 0.048). Spiritual well-being was improved in UC + PAL versus UC-alone patients (FACIT-Sp difference = 3.98 points; p = 0.027). Randomization to UC + PAL did not affect rehospitalization or mortality.

Conclusions: An interdisciplinary palliative care intervention in advanced HF patients showed consistently greater benefits in quality of life, anxiety, depression, and spiritual well-being compared with UC alone. (Palliative Care in Heart Failure [PAL-HF]; NCT01589601).

Keywords: heart failure; palliative care; quality of life.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Mean quality-of-life measures by treatment group over time for the primary outcome measures
Panel A displays the KCCQ overall summary score. Panel B displays the FACIT-Pal score. For both scales, higher values represent better quality of life. A 5-point change for the KCCQ overall summary score is considered clinically significant. A 10-point change is considered clinically meaningful for the FACIT-Pal score.
Figure 1
Figure 1. Mean quality-of-life measures by treatment group over time for the primary outcome measures
Panel A displays the KCCQ overall summary score. Panel B displays the FACIT-Pal score. For both scales, higher values represent better quality of life. A 5-point change for the KCCQ overall summary score is considered clinically significant. A 10-point change is considered clinically meaningful for the FACIT-Pal score.
Figure 2
Figure 2. Mean quality-of-life measures by treatment group over time for the key secondary outcome measures
Panel A displays the FACIT-Sp score, panel B displays the HADS-depression score, and panel C displays the HADS-anxiety score. For the FACIT-Sp scale, higher scores represent increased spirituality across the range of religious traditions. The HADS scale is divided into anxiety and depression subscales, giving the optimal sensitivity and specificity for the presence of the corresponding psychiatric symptoms. Higher scores indicate worse symptoms.
Figure 2
Figure 2. Mean quality-of-life measures by treatment group over time for the key secondary outcome measures
Panel A displays the FACIT-Sp score, panel B displays the HADS-depression score, and panel C displays the HADS-anxiety score. For the FACIT-Sp scale, higher scores represent increased spirituality across the range of religious traditions. The HADS scale is divided into anxiety and depression subscales, giving the optimal sensitivity and specificity for the presence of the corresponding psychiatric symptoms. Higher scores indicate worse symptoms.
Figure 2
Figure 2. Mean quality-of-life measures by treatment group over time for the key secondary outcome measures
Panel A displays the FACIT-Sp score, panel B displays the HADS-depression score, and panel C displays the HADS-anxiety score. For the FACIT-Sp scale, higher scores represent increased spirituality across the range of religious traditions. The HADS scale is divided into anxiety and depression subscales, giving the optimal sensitivity and specificity for the presence of the corresponding psychiatric symptoms. Higher scores indicate worse symptoms.
Central Illustration
Central Illustration. The PAL-HF study randomized 150 patients with advanced heart failure to usual care or usual care + a multidimensional palliative care intervention
The co-primary endpoints were quality of life measured by the Kansas City Cardiomyopathy Questionnaire and the Functional Assessment of Chronic Illness Therapy - Palliative Care scale. Patients who received the palliative care intervention had significantly better quality of life measured by both instruments.
See this image and copyright information in PMC

Comment in

References

    1. Yancy CW, Jessup M, Bozkurt B, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016 May 17; pii: S0735-1097(16)33024-8. - PubMed
    1. Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013;127:143–52. - PubMed
    1. Bergethon KE, Ju C, DeVore AD, et al. Trends in 30-day readmission rates for patients hospitalized with heart failure: findings from the Get With the Guidelines-Heart Failure Registry. Circ Heart Fail. 2016;9 pii:e002594. - PMC - PubMed
    1. Selman L, Beynon T, Higginson IJ, Harding R. Psychological, social and spiritual distress at the end of life in heart failure patients. Curr Opin Support Palliat Care. 2007;1:260–6. - PubMed
    1. Bekelman DB, Havranek EP, Becker DM, et al. Symptoms, depression, and quality of life in patients with heart failure. J Card Fail. 2007;13:643–8. - PubMed

Publication types

Associated data